Up next

Autoplay

Montelukast (Singulair) Side Effects Support and Discussion Group FDA Speech

1 Views • 08/26/25
Share
Side Effects
Side Effects
Subscribers
0

On September 27, 2019 the FDA Pediatric Advisory Committee reviewed the safety of the widely prescribed medication Montelukast due to the continuously reported neuropsychiatric side effects. Kammy Pany spoke on behalf of the then 7,300 members who have suffered and are looking for a black box warning, medication guide and a Risk Evaluation and Mitigation strategy for safer use of this medication.

Show more
0 Comments sort Sort By

Up next

Autoplay